That means informed consent that mirrors the oral finasteride risk profile, explicit instructions on application technique and transfer prevention, documentation that the patient understands the off-label nature of the formulation, and selection of a PCAB-accredited compounding pharmacy that validates potency and ingredient quality
Chau KK, Zhang P, Urresti J, Amar M, Pramod AB, Chen J, et al
[9] Using retatrutide outside of an approved, ethics-committee-reviewed clinical trial carries significant risks, as research-grade peptides are not subject to the same manufacturing standards, purity controls, or safety oversight as licensed medicines
[3] What Lies Ahead For AOD-9604 In the future, should the cosmeceutical potential of AOD-9604 be fully realized, the implications of decreased cellulite and subcutaneous fat for health and wellness enthusiasts can be wide-ranging, including both aesthetic and health benefits